newsfilter
← Latest News
GlobeNewswire·

Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy

Investigational travatrelvir demonstrated preclinical activity against multiple SARS-CoV-2 variants Orally administered novel protease inhibitor does not require ritonavir co-administration First-in-Human study to